Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Hologic, Inc.

< Previous 1 2 3 Next >
Hologic Announces FDA Approval of Aptima® CMV Quant Assay for Human Cytomegalovirus
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Webcast Presentation at Upcoming Investor Conference
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Announces Financial Results for Second Quarter of Fiscal 2022
From Hologic, Inc.
Via Business Wire
Tickers HOLX
American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Now Includes Breast Cancer Index™ to Guide Decisions about Extended Endocrine Therapy
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2022 on Wednesday, April 27, 2022
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Webcast Presentations at Upcoming Investor Conferences
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Announces Financial Results for First Quarter of Fiscal 2022
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Launches First-Ever National Advertising Campaign Featuring Mary J. Blige
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic’s Sustainability Leadership Makes Company “A Global Force for Good”
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2022
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Announce Financial Results for the First Quarter of Fiscal 2022 on Wednesday, February 2, 2022
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Adds Aptima SARS-CoV-2 Assay to its Global Access Initiative in Resource-Limited Countries
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Webcast Presentation at the 40th Annual J.P. Morgan Healthcare Conference
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Launches Panther Trax for High Volume Molecular Testing
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Presents Breast Cancer Index™ Data at SABCS 2021 Showing Net Benefit Predictive Value for Endocrine Therapy Continuation
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Closes on Acquisition of Bolder Surgical
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Pledges to Donate $5 Million to Improve Women’s Health, STEM Education and Social Justice
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic’s COVID-19 Tests Detect Omicron Variant
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Host Innovative Product Experiences and Medical Education Sessions On-site and Virtually at RSNA 2021
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Webcast Presentation at Upcoming Virtual Investor Conference
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Launch the NovaSure® V5 Global Endometrial Ablation Device at Upcoming American Association of Gynecologic Laparoscopists 50th Global Congress
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2021
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic’s Multiplex COVID-19/Flu Test Now Commercially Available in North America and Europe
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Debuts Documentary-Style Film Highlighting One Woman's Breast Cancer Journey Timed to Breast Reconstruction Awareness Day
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Acquire Bolder Surgical for $160 Million, Expanding its Surgical Franchise
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2021 on Monday, November 1, 2021
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Rings Nasdaq Opening Bell for 15th Time to Kick Off Breast Cancer Awareness Month
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic Releases Results of Inaugural Global Women’s Health Index – First Study Representing the Health of 2.5 Billion Women and Girls
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences
From Hologic, Inc.
Via Business Wire
Tickers HOLX
Anthem, Nation’s Second Largest Health Plan, Now Covers Hologic’s Acessa Procedure as a Treatment for Uterine Fibroids
From Hologic, Inc.
Via Business Wire
Tickers HOLX
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.